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Background and aim: In the diagnosis of cerebral cavernous malformations (CCMs) magnetic resonance imag-
ing is established as the gold standard. Conventional MRI techniques have their drawbacks in the diagnosis of
CCMs and associated venous malformations (DVAs). The aim of our study was to evaluate susceptibility
weighted imaging SWI for the detection of CCM and associated DVAs at 7 T in comparison with 3 T.
Patients and methods: 24 patients (14 female, 10 male; median age: 38.3 y (21.1 y–69.1 y) were included in
the study. Patients enrolled in the study received a 3 T and a 7 T MRI on the same day. The following
sequences were applied on both ﬁeld strengths: a T1 weighted 3D GRE sequence (MP-RAGE) and a SWI
sequence. After obtaining the study MRIs, eleven patients underwent surgery and 13 patients were followed
conservatively or were treated radio-surgically.
Results: Patients initially presented with haemorrhage (n=4, 16.7%), seizures (n=2, 8.3%) or other neurol-
ogy (n=18, 75.0%). For surgical resected lesions histopathological ﬁndings veriﬁed the diagnosis of CCMs. A
signiﬁcantly higher number of CCMs was diagnosed at 7 T SWI sequences compared with 3 T SWI (pb0.05).
Additionally diagnosed lesions on 7 T MRI were signiﬁcantly smaller compared to the initial lesions on 3 T
MRIs (pb0.001). Further, more associated DVAs were diagnosed at 7 T MRI compared to 3 T MRI.
Conclusion: SWI sequences at ultra-high-ﬁeld MRI improve the diagnosis of CCMs and associated DVAs and
therefore add important pre-operative information.© 2012 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
Cerebral cavernousmalformations (CCM) are a heterogeneous group
of lesions mostly described as a mulberry like assembly of vascular sinu-
soids with varying vessel diameter and wall thickness, lined by a thinations; DVA, developmental
ging.
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Inc. Open access under CC BY-NC-ND lendothelium lacking smoothmuscle and elastin, surrounded by hemosid-
erin deposits and gliosis (Frischer et al., 2008; Raychaudhuri et al., 2005).
In the diagnosis of CCM magnetic resonance imaging has proven to
be the gold standard. However, conventional MRI techniques also have
their drawbacks. If CCM lesions are intact and have not bled, they may
be almost invisible except for a faint or ill-deﬁned non-speciﬁc blush
of enhancement after contrast administration. In addition, the lack of
ﬂow-related signal intensity makes CCMs undetectable on conventional
MR angiographic techniques (Bertalanffy et al., 2002; Tsui et al., 2009).
It is of further importance that according to the pertinent litera-
ture an average of 13–30% of cavernomas are associated with venous
malformations (Bertalanffy et al., 2002; Porter et al., 1999). However,
several studies showed that the prevalence of cavernomas associated
with DVAs is underestimated using routine MRI and that small ve-
nous malformations are only diagnosed during surgery (Bertalanffy
et al., 2002; Kamezawa et al., 2005; Porter et al., 1999; Wurm et
al., 2007). Moreover, it has been described that CCMs with associated
venous anomalies present with a higher risk of clinically signiﬁcanticense.
Table 1
MRI speciﬁcs.
7 T 3 T
T1 MP‐RAGE:
Image matrix 320×320 320×308
Resolution 0.7 mm isotropic 0.8 mm isotropic
Slices 208 192
Parallel imaging factor 2 2
TR/TI/TE 3800/1700/3.55 ms 2190/1300/3.02 ms
Acquisition time 7:30 min 11:16 min
SWI sequence:
TE 15 ms 29 ms
TR 28 ms 42 ms
Image-matrix 704×704 pixels 384×384 pixels
Slices 96 88
Parallel imaging factor 2 2
Acquisition time 10.18 min 11:03 min
Resolution 0.3×0.3×1.2 mm 0.6×0.6×1.5 mm
Table 1 shows detailed MRI speciﬁcs for the 7 T and 3 T study images.
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The ﬁeld of magnetic resonance imaging has experienced huge
developments in recent years. This especially holds true for a tech-
nique formerly known as MR venography. Susceptibility-weighted
imaging sequences are highly sensitive for paramagnetic blood
degradation products such as desoxyhemoglobin and hemosiderin
and enable the exact visualisation even of small vessels. In contrast to
conventional MRI sequences that rely on the reading of magnitude in-
formation, SWI uses additional phase data. In summary, susceptibility-
weighted imaging is a high-spatial resolution, three-dimensional,
gradient-echo technique. SWI offers information about any tissue
that has a different susceptibility than its surrounding structures such
as deoxygenated blood, hemosiderin, ferritin, and calcium. The higher
the magnetic ﬁeld, the higher this susceptibility effect and thus the
better the SWI image of e.g. small cerebral white matter veins. This
is caused by a higher sensitivity for phase effects, a higher signal to
noise ratio and a higher resolution (Haacke et al., 2004, 2009; Ladd,
2007; Mittal et al., 2009).
How or if those effects on ultra-high-ﬁeld imaging improve the
diagnosis of various cerebral pathologies has yet to be evaluated.
Few recent studies provide initial data that ultra‐high-ﬁeld magnetic
resonance imaging at 7 T improves the detection of cerebral cavern-
ous malformations when compared to 1.5 T (Dammann et al., 2010;
Novak et al., 2003; Schlamann et al., 2010). Our study therefore
aims to evaluate SWI sequences at 7 T for the detection of CCM and
associated DVAs in comparison with SWI at 3 T for the ﬁrst time in
a larger series of CCM patients.
2. Patients and methods
2.1. Sample characterisation and ethical approval
Before commencement of the study, ethical approval was granted
by the ethics commission of the Medical University of Vienna. All pa-
tients admitted to the Department of Neurosurgery of the Medical
University of Vienna between March 2010 and June 2011 with the
diagnosis of a cerebral cavernous malformation on the initial routine
MRI were screened for this study. Patients therefore presented with
lesions on their initial routine MRIs resembling popcorn like struc-
tures and were hypointense on T2 weighted images and negative
on MR-angiography. Signs of intra- or extralesional haemorrhages
(hyperintense on T2 weighted and T1 weighted imaging if in the sub-
acute stage) were additionally observed. Inclusion criteria were ap-
plied as follows: no prior therapy of the lesions, above 18 years of
age, exclusion of pregnancy, exclusion of an allergy to the contrast
medium, exclusion of further contraindications for MRI (cardiac pace-
maker,metallic cardiac valves, surgical clips, implanted electrical infusion
pump, tattoos, piercing, etc.), normal current creatinine level (preven-
tion of nephrogenic systemic ﬁbrosis), exclusion of claustrophobia.
Clinical data were recorded accordingly: age, sex, presenting
symptoms, localisation of initial diagnostic lesion(s). After informed
consent patients underwent their 3 T and 7 T study MRIs on the
same day. Twenty-four patients (14 female, 10 male) with a median
age of 38.3 years (21.1 y–69.1 y) were thus included in the study.
After obtaining the study MRIs, patients were treated according to
the state of the art treatment plan of the Department of Neurosur-
gery. Thus, 11 patients underwent surgery of their clinically signiﬁ-
cant lesions, 12 patients were followed conservatively and 1 patient
underwent radio-surgery. For all surgical patients the diagnosis of
a CCM could be proven histo-pathologically.
2.2. MRI speciﬁcs
Routine MRI sequences were a heterogeneous group of 1.5 T and
3 T sequences but in all cases including T2 weighted sequences andT1 weighted sequences with and without contrast enhancement.
Still, the routine MRI sequences were only used to include patients
in the presented study. In order to directly compare SWI at 3 T and
at 7 T for the detection of CCMs, patients were evaluated with our
standardised study protocol. Patients underwent a 3 T and a 7 T
MRI on the same day. All patients were examined on a 7 T system
(Magnetom, Siemens, Erlangen, Germany) using a 32 channel RF coil
(Nova Medical, Wilmington, USA). T1-weighted data were acquired
using an MP‐RAGE sequence. Afterwards a three-dimensional, fully
ﬁrst-order ﬂow-compensated gradient-echo SWI sequence was per-
formed. The same protocol including an MP‐RAGE and SWI was per-
formed on a 3 T MR system (Tim Trio, Siemens, Erlangen, Germany).
For detailed MR sequence parameters see Table 1.
2.3. Data evaluation
MRI evaluation was performed by a senior radiologist (S.T.) and a
junior radiologist (S.G.) in consensus blinded to clinical and initial di-
agnostic data as has been described before (Pinker et al., 2007). A
third co-worker entered the data into the clinical database (J.M.F.).
The number of detected lesions on 3 T and 7 T SWI sequences as stat-
ed above was recorded. Additionally, the diagnosis of associated ve-
nous anomalies was made. Lesion speciﬁcs such as localisation and
volume were also recorded. For all patients of the surgical group the
diagnosis of a CCM could be proven histo-pathologically. The diagno-
sis of associated venous malformations was also evaluated intraoper-
atively for all patients of the surgical group. Artefacts on 7 T scans
were rated accordingly: none/minor, present but evaluation possible,
major evaluation hardly possible. Lesion volumewas evaluated on 7 T
scans for all lesions in order to enable comparison of lesions. Lesion
volume was calculated by using the following formula: A×B×C/2.
(A) is the largest diameter and (B) is the perpendicular diameter of
lesion. (C) was obtained by summing up the thicknesses of the slices
where the lesion was visible (Pantano et al., 1999).
2.4. Statistical analysis
The presented study was prospectively designed. A prospective
cohort study, more accurate a comparative study (3 T vs. 7 T) was
applied. Due to the grouping of patients after the state of the art treat-
ment plan, the study was not randomised. Patients' data were admin-
istered in an anonymous database. Due to the uneven distribution
of our data, statistical analysis was performed with nonparametric
tests. Descriptive analysis included median value and range as well
as number and percentage. Statistical calculations included Wilcoxon
test and McNemar test for paired samples as well as Mann–Whitney
test. p-Valuesb0.05 were considered statistically signiﬁcant. SPSS
Fig. 1. In Fig. 1A the number of lesions on the different available MRI scans is depicted.
Patients presented with a heterogeneous group of initial diagnostic MRIs thus leading
to the radiological diagnosis of CCM. Initially only 2 patients were diagnosed with mul-
tiple lesions. After study inclusion and informed consent standardised SWI and T1
scans on 3 T and 7 T were performed and evaluated. Signiﬁcantly more lesions were
detected on SWI at 7 T compared to 3 T scans, thus leading to the diagnosis of 6 addi-
tional patients with multiple lesions. Fig. 1B compares the volume of diagnosed CCMs.
The volume of the initial diagnosed lesion on 3 T MRI is compared with the addition-
ally diagnosed CCMs that were diagnosed only on 7 T SWI sequences. It is important
to note that the additionally diagnosed CCMs on 7 T SWI sequences are signiﬁcantly
smaller than the CCMs that were also diagnosed on the 3 T sequences. Lesions volume
was evaluated on 7 T SWI scans for all lesions. Box plots represent median value (50th
percentile) and range. Outliers (values that are between 1.5 and 3 times the interquartile
range) are marked with a circle. Extreme values (values that are more than 3 times the
interquartile range) aremarkedwith an asterisk. In order to simplify graphic presentation
one extreme value of initial diagnostic lesion volume has been cut in Fig. 1B.
118 J.M. Frischer et al. / NeuroImage: Clinical 1 (2012) 116–12017.0 statistical software system (SPSS Inc., Chicago, IL) was used
for data administration and statistical calculations.
3. Results
The majority (n=18, 75.0%) of patients initially presented with
minor neurological symptoms. Remaining patients presented with
haemorrhage (n=4, 16.7%) and seizures (n=2, 8.3%). The majority
of patients (n=19, 79.1%) showed single, supratentorial or single
infratentorial (n=3, 12.5%) lesions. Only 2 patients (8.3%) were diag-
nosed with multiple lesions on their initial routine MRI. All 24 patients
included in this study tolerated the MRI examinations well. Artefacts
on 7 T MRI scans were none/minor (n=12, 50.0%) or present but eval-
uation possible (n=10, 41.7%) in the majority of patients. In two pa-
tients (8.3%) artefacts severely interfered with the evaluation.
Initial routine MRIs were a group of heterogeneous MR protocols
but in all cases included T2 weighted MR sequences. In most of
the cases contrast enhanced sequences were available. All lesions on
the initial routine MRI were also identiﬁed on the 3 T and 7 T study
examinations. As shown in Fig. 1A, signiﬁcantly more lesions were
detected on 7 T scans (pb0.05) compared to 3 T scans. Thus, six addi-
tional patients were diagnosed with multiple lesions. However, lesion
size of those additional detected lesions on 7 T MRI sequences was
signiﬁcantly smaller when compared to the initially diagnosed lesions
thatwere already diagnosed on 3 T sequences (pb0.001) (Fig. 1B). Me-
dian volume of initial diagnosed lesions was 0.9 cm3 (0.1–17.5 cm3).
Median volume of additionally diagnosed lesions on 7 T SWI sequences
only reached 0.01 cm3 (0.01 to 0.1 cm3). Direct comparison of lesion
volume evaluated at 7 T versus 3 T revealed that lesion volume on 7 T
MRI scans was overestimated of about 13.8% (median value).
No patient was diagnosed with an associated venous malformation
on routine MRI scans. On the SWI 3 T scans 3 patients were diagnosed
with an associated venous malformation. Five additional patients with
associated venous malformations were found on 7 T SWI scans. Thus,
8 patients were diagnosed with an associated DVA that have not been
detected on routine MRI scans (pb0.01). Among the subgroup of 11
surgical patients, two patients were diagnosed with associated DVA
on 7 T scans which was also proven during surgery (Fig. 3). Consecu-
tively, the absence of associated DVAs as diagnosed at 7 T MRI was
also proven intraoperatively in the remaining nine patients. In order
to illustrate the above mentioned data two case reports are presented
in Figs. 2 and 3 (see ﬁgure legends for detailed information).
4. Discussion
Already in 1997 the ﬁrst article on susceptibility weighted imaging
had been published. Still, SWI has yet to be included into routine
clinical neuroimaging protocols for CCMs. The necessity of longer
echo-times for opposed phase conditions and higher spatial resolution
led to seriously long acquisition times at low ﬁeld strength with lower
signal to noise ratio and increased motion artefacts (Dammann et al.,
2010; Reichenbach et al., 1997). With the availability of high and
ultra-high ﬁeld strength conditions improved for susceptibility weight-
ed imaging. Initial data suggest that ultra‐high-ﬁeld magnetic reso-
nance imaging at 7 T improves the detection of cerebral cavernous
malformations when compared to 1.5 T (Dammann et al., 2010;
Novak et al., 2003; Schlamann et al., 2010). Still, there is an ongoing dis-
cussion in the pertinent literature if the increased sensitivity of CCMde-
tection reported by previous authors is due to high ﬁeld strength per se
or to SWI sequences since for some data lesion prevalence has been
evaluated at high ﬁeld using SW imaging and at lower ﬁeld using GRE
sequences (Campbell et al., 2010; Schlamann et al., 2010). So far a sys-
tematic study comparing SWI sequences at 3 T and 7 T protocols has
not been described.
Our study clearly demonstrates that using SWI at 7 T has a higher
sensitivity for the detection of CCMs and associated DVA detectioncompared to SWI at 3 T. Therefore, our results substantially add
to initial data and are conducted for the ﬁrst time in a larger series
of CCM patients, with the additional evaluation of associated DVAs.
The detection of until now occult cerebral cavernous malformations
may play an important role in the clinical management and diagnosis
of drug resistant and cryptogenic seizure patients, as stated before
(Schlamann et al., 2010). There is general consensus in the pertinent
literature that seizure disorders represent the most frequent clinical
symptoms of supratentorial cavernous malformations. Although the
cavernous malformation itself presumably does not generate seizures,
the epileptic effect on the surrounding tissue is most likely related to
hemosiderosis and reactive gliosis, which are caused by recurring
micro-haemorrages into the surrounding brain parenchyma (Bertalanffy
et al., 2002; Robinson et al., 1991; Stavrou et al., 2008). The surgical
Fig. 2. Fig. 2 depicts pre-operative images of a female patient, 27 years old who initially presented with severe headache and visual disturbances. Consecutively a parietal CCM with
haemorrhage could be diagnosed (Fig. 2A, B; 3 T T2) on initial diagnostic T2 images. This lesion could obviously also be identiﬁed and 7 T SWI scans (Fig. 2C). However, evaluating
the 7 T scans additional 5 lesions could be detected (Fig. 2D–F; 7 T SWI mIP). The parietal lesion was surgically removed and the diagnosis of a CCM was histo‐pathologically veriﬁed.
Retrospectively one of the additional diagnosed lesions (Fig. 2E) could have been detected on the 3 T scans. At 3 months after surgery the patient is free of any neurological symptoms.
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described as beneﬁcial for seizure treatment in many patient series
(Baumann et al., 2007; Bertalanffy et al., 2002; Cappabianca et al., 1997;
Stavrou et al., 2008).
Drawbacks and problems of ultra-high-ﬁeld SWI scans have
been discussed previously: especially higher susceptibility artefacts in
brain areas close to pneumatised bones such as the skull base as well
as overestimation of lesions size of about 11% have been described
(Dammann et al., 2010; Schlamann et al., 2010). In the presented
study, artefacts severely interfered with the evaluation only in two pa-
tients. Still, the overestimation of lesion size has also been noted in our
study to a comparable extent. The overestimation of lesion size is based
on the increased susceptibility effect of hemosiderin on SWI with the
increasing ﬁeld strength. This effect has to be considered when usingFig. 3. Depicted are images of a female patient, 27 years old who initially presented with hea
intralesional haemorrhage. On the 3 T scan no associated venous malformation was diagnos
(Fig. 3B arrow) that could also be seen during surgery (Fig. 3C arrow). The diagnosis of a CC
from a partial paresis of the right oculomotor nerve.ultra-high-ﬁeld SWI scans for pre-operative as well as radiosurgical
planning and possible implementation into neuronavigation devices.
Naturally, this consideration is of paramount importance for deep
seated lesions or lesions in other eloquent areas such as the brainstem
(Campbell et al., 2010; Dammann et al., 2010; Schlamann et al., 2010).
The association of CCMs and venous malformations and its clinical
implications is still controversially discussed. Those developmental ve-
nous anomalies are characterised by theoccurrenceof oneormore path-
ological veins. Porter et al. showed in their series of surgically resected
brainstem cavernomas a 100% association with venous malformations.
However, only 32% of those DVAs were diagnosed on MRI (Bertalanffy
et al., 2002; Porter et al., 1999). Those ﬁndings and other studies
led to the conclusion that the prevalence of cavernomas associated
with DVAs is underestimated using routine MRI and that small venousdache and cranial nerve deﬁcits. MRI revealed a CCM in the right cerebral peduncle with
ed (Fig. 3A). In comparison 7 T SWI sequences revealed an associated pathological vein
M was proven histo-pathologically. Three months after surgery the patient still suffers
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ciated venous malformations were diagnosed on the initial routine
MRI thus adding to previously published data (Bertalanffy et al., 2002;
Kamezawa et al., 2005; Porter et al., 1999; Wurm et al., 2007). One ex-
planation regarding this circumstance is that if CCM lesions are intact
and have not bled, they may be almost invisible except for a faint or
ill-deﬁned non-speciﬁc blush of enhancement after contrast adminis-
tration. In addition, the lack of ﬂow-related signal intensity makes
CCMs undetectable on conventional MR angiographic techniques. On
the other hand DVAs are mainly detected on images after contrast en-
hancement (Bertalanffy et al., 2002; Tsui et al., 2009).
However, the accurate pre-operative diagnosis of DVAs is essential
since it has been described that cavernomas with associated develop-
mental venous anomalies present with a higher risk of clinically sig-
niﬁcant haemorrhages (Bertalanffy et al., 2002; Porter et al., 1999;
Wurm et al., 2007). Therefore, it is important to ﬁnd a diagnostic se-
quence for the accurate detection of both CCMs and associated DVAs.
In the patient series of Pinker et al. no associated DVA could be detected
on 3 T SWI scans (Pinker et al., 2007). In our series DVAs could be
detectedwith SWI at 3 T but to a higher numberwith SWI at 7 T. Impor-
tantly, we could verify our results in our subgroup of surgical resected
patients thus conﬁrming the 7 T data with 100% accuracy. 7 T SWI
scans seem to enable the detection of CCMs and associatedDVAswithout
the administration of contrast enhancement. It is tempting to speculate
that the administration of contrast enhancement at 7 Tmight further in-
crease the detection rate of associated venous malformations since the
resolution at 7 T is improved. However, preliminary data in brain tu-
mours have shown that gadolinium contrast enhancement was similar
between ﬁeld strengths (Lupo et al., 2011; Moenninghoff et al., 2010).
One drawback of the study is of course the veriﬁcation of observa-
tions at ultra-high-ﬁeld 7 T MRI. As it has been described before, this
is a problem of every new method (Schlamann et al., 2010). Other
reasons for hypointense lesions on SWI images have to be taken
into account. However, as described above, SWI sequences are highly
sensitive to paramagnetic blood degradation products such as hemo-
siderin. What is seen in the diagnosis of CCMs on SWI is the hemosid-
erin rim in larger cavernous malformations or the hemosiderin due to
micro-haemorrhage in smaller lesions. As a differential diagnosis cal-
ciﬁcations or micro-angiopathic haemorrhages are possible although
they are not common among young and otherwise healthy patients
as presented in this study (Blitstein and Tung, 2007; Dammann et
al., 2010; Haacke et al., 2009).
In conclusion susceptibility weighted imaging at 7 T improves the
diagnosis of cerebral cavernous malformations and associated venous
malformations and substantially adds to clinical and pre-operative
information. Further, with the use of 7 T imaging it will be possible
to gain new insights into lesion dynamics via long term follow up of
conservatively and radio-surgically treated patients.References
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